Skip to main content
Biome Grow Inc. logo

Biome Grow Inc. — Investor Relations & Filings

Ticker · BIO ISIN · CA09075M1023 LEI · 529900FESG9W6XF7OE95 CSE Manufacturing
Open in API
Filings indexed 298 across all filing types
Latest filing 2023-12-01 Regulatory Filings
Country CA Canada
Listing CSE BIO

About Biome Grow Inc.

www.biomegrow.com

Biome Grow Inc. is a company engaged in the production and distribution of cannabis products. The organization operates through a structure of wholly-owned subsidiaries, which include licensed producers such as HighlandGrow and THC Dispensaries Canada Inc. Biome Grow's operational focus is concentrated in the Atlantic regions, where it secures supply and production agreements to serve provincial markets, including Nova Scotia and Prince Edward Island. The company leverages its regional infrastructure and experience to pursue broader national and international business interests in the regulated market.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2023-12-01 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Management’s Discussion and Analysis' (MD&A) for the three and nine months ended September 30, 2023 and 2022. It contains detailed commentary on the company's financial condition, operations, quarterly financial information, and forward-looking statements. The text explicitly states that it supplements the unaudited condensed interim consolidated financial statements for the periods mentioned. The presence of quarterly financial data and discussion of interim periods indicates this is a comprehensive interim report rather than a brief announcement or certification. The document length is substantial (15,000 characters), and it contains substantive financial data and analysis. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). 9M 2023
2023-12-01 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Condensed Interim Consolidated Financial Statements' for the three and nine months ended September 30, 2023 and 2022, indicating it is a financial report covering a period shorter than a full fiscal year. It includes detailed financial statements such as Statements of Financial Position, Loss and Comprehensive Loss, Cash Flows, and Changes in Shareholder's Deficiency, along with notes explaining accounting policies and going concern assumptions. The document is unaudited and prepared under IFRS IAS 34 Interim Financial Reporting standards. The length of the document (15,000 characters) and the presence of substantive financial data confirm it is a full interim report, not just an announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). 9M 2023
2023-12-01 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate by the CFO of Biome Grow Inc. It certifies the review and fair presentation of interim financial statements and interim MD&A for the period ended June 30, 2023. The document is primarily a certification letter and does not contain actual financial data or substantive financial analysis. It references interim filings but does not include them. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is short (3022 characters), consistent with a certification letter rather than a full report.
2023-08-28 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate by the CEO of Biome Grow Inc. It certifies the review and fair presentation of interim financial statements and MD&A for the period ended June 30, 2023. The document is a certification letter and does not contain actual financial data or the interim report itself. It explicitly states it is a certification related to interim filings, not the filings themselves. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than as the interim report (IR). The document length is short (3005 characters), consistent with a certification letter rather than a full interim report.
2023-08-28 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Management’s Discussion and Analysis' (MD&A) for the three and six months ended June 30, 2023 and 2022. It contains detailed commentary on the company's financial condition, operations, quarterly financial information, and forward-looking statements. The text explicitly states that it supplements the unaudited condensed interim consolidated financial statements for the periods mentioned. The presence of quarterly financial data and discussion of interim results indicates this is a comprehensive interim report. The document length is 15,000 characters, which is substantial and contains substantive financial data and analysis, not just an announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q2 2023
2023-08-28 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.